Cancer Therapy First-in-Human Lucite Commemorative

Custom Lucite, incorporating an embedded vial, celebrating the first-in-human dosing in a Phase 1 clinical trial of cancer treatment developed by biotech company Immunome. (25ALJ040)

Back view of a custom Lucite with an embedded vial marking the first patient dosed with a cancer therapy.